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ABSTRACT
Objectives: Conflicting opinions about laparoscopic
myomectomy (LM) are still present regarding indications
and risks related to reproductive outcome. We reviewed
our 13-year experience (1) to identify risk factors or
changes in methods that have improved our myomectomy
technique and (2) to evaluate how the learning curve and
improved surgical devices influenced our procedures, and
(3) to study the myomectomy scar with a power color
Doppler ultrasound (US).
Methods: From January 1991 to December 2003, we stud-
ied 332 patients who underwent laparoscopic myomectomy.
We analyzed, as the learning curve, how the introduction of
the Steiner morcellator, the use of vasoconstrictive agents,
and different techniques of suturing have influenced param-
eters such as operating time and blood loss.
Results: We performed 332 single or multiple myomec-
tomies for symptomatic myomas. Most patients (47%) had
more than one myoma, with a maximum of 8 per patient
(average myomas removed for patients: 2.23, range 1 to
8). Myoma size ranged from 1cm to 20 cm (mean,
60.20SD27.1 mm). Myomas 4cm were removed during
myomectomy for larger ones. The conversion rate to lap-
arotomy was 1.51%. The average drop in hemoglobin
concentration was 1.06SD0.86 g/100 mL (range, 0.7 to
2.2 g/100 mL). No blood transfusions were required. No
major intraoperative complications occurred. The dura-
tion of the procedure ranged from 30 minutes to 360
minutes (mean, 124SD52.6). The dimensions of the my-
omas removed increased with experience (4.91SD2.2
cm of the earlier cases to 6.76SD2.7 of the latest group,
P0.000). The learning curve positively influenced the
length of the procedures in the first cases. The introduc-
tion of electromechanical morcellation in 1996 reduced
the procedure time. Data showed significantly reduced
Hb drop after the introduction in 1998 of vasoconstrictive
agents (Hb 1.62 g/100 mL versus 0.95; P0.001). The
running suture offered few advantages in terms of proce-
dure time. However, the drop in hemoglobin was advan-
tageous (Hb 1.1 g/100mL vs 0.61, P0.01). The overall
rate of intrauterine pregnancy following LM was 65.5%.
No uterine ruptures occurred. We had 2 serious postop-
erative complications:
Conclusion: With increased experience, the technical im-
provements and clinical results have changed our approach
and decision making regarding laparoscopic myomectomy.
Our results and extremely low conversion rate suggest that
laparoscopic myomectomy is a safe and reliable procedure
even in the presence of multiple or enlarged myomas.
Key Words: Laparoscopic myomectomy, Morcellator,
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INTRODUCTION
Laparoscopic myomectomy is no longer a new procedure.
Kurt Semm1 reported the first laparoscopic myomectomy
in 1979. Recognized and at last proved advantages are
those related to minimal-access surgery, such as fast re-
covery and reduced postoperative pain and adhesion for-
mation.2 Nevertheless, laparoscopic myomectomy is still a
debated operation whose feasibility, indications, and risks
are still matters of discussion.3–6 We statistically reviewed
our experience over a 13-year period1 to identify risk factors
or changes in methods that have improved our myomec-
tomy technique,2 to evaluate how the learning curve has
influenced our procedures, and3 to study the myomectomy
scar with a power color Doppler ultrasound (US).
METHODS
From January 1991 to December 2003, we followed 332
patients who underwent single or multiple myomectomies
for symptomatic myomas. We included in the study only
patients who signed an informed consent and agreed to
follow-up. We divided the patients into 3 groups: Group A
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SCIENTIFIC PAPER(1991 to 1995), which represents the pioneering years, when
electro-mechanical morcellation was not available and the
learning curve was steep; Group B (1996 to 1997), identified
by the introduction of the Steiner electromechanical morcel-
lator. The morcellation time was less demanding and by that
time the learning curve was considered completed; and
Group C (1998 to 2003) marked by the introduction of the
use of vasoconstrictive agents, years during which different
types of sutures were experimented with and more challeng-
ing myomectomies were performed.
Diagnosis of myomas was achieved by transvaginal and
abdominal ultrasonography. Hysteroscopy was performed
when ultrasounds showed the probable involvement of the
endometrium. Indications were infertility, recent and signif-
icant uterine enlargement, and symptoms (pelvic pain,
menometrorrhagia and abnormal bleeding). Inclusion crite-
ria were age 42 years, the presence of at least 1 symptom-
atic myoma 4cm, the number of myomas 8, and the
absence of submucous myomas that could be removed by
hysteroscopy. All patients received general anesthesia. Two
surgeons performed all surgical procedures. For each pa-
tient, the total operating time was recorded from the anes-
thesiology charts. Laparoconversion was defined as the sub-
stitution of laparoscopy by laparotomy for intraoperative
complications or difficulties in completing the procedure.
Hemoglobin drop and the incidence of febrile morbidity
(indicated by a temperature of 38°C in 2 consecutive mea-
surements 6h apart, excluding the first 24h) were reported.
The length of hospital stay, in days of hospitalization after
surgery, was noted. Comparisons among the 3 groups were
made especially regarding operative time, myoma character-
istics, and blood loss. To try to avoid confounding factors
like number of myomas and myoma type and size, we
considered for comparison only those patients with 1 intra-
mural myoma 6 cm to 8 cm in diameter.
Transvaginal ultrasound (US) examination was performed
before and after surgery (to verify the adequate healing of
the myomectomy scar). We studied vascularization of the
uterine wound after laparoscopy by means of transvaginal
color Doppler ultrasonography in comparison with vas-
cularity of the contralateral intact myometrium. In this
way, it was also possible to check for defective healing
(hematomas, indentations) along the uterine scar in the
immediate postoperative period. Transvaginal color flow
Doppler was used to study myometrial and fibroid arterial
supply. The equipment used was Esaote Biomedica color
Doppler AU4 IDEA with a transvaginal multi-frequency (5
to 6.5 to 7.5 MHz) probe for imaging and a pulsed Doppler
system (3.5 to 4.7 MHz) for blood flow analysis. Wall filters
(100 Hz) were used to eliminate low frequency signals.
Blood flow impedance expressed as resistance index (RI),
pulsatility index (PI), and blood velocity were preoperatively
calculated from the fifth to the eighth day of the menstrual
cycle to study blood flow in the main arteries supplying
identifiable fibroids and in the arteries of the contralateral
myometrium. Thirty patients were randomized for laparo-
scopic or laparotomic myomectomy. Examinations were
performed before, between 7 and 15, and between 30 and
45 days after the surgery. Blood flows were measured in the
arteries supplying the myomectomy wound and in the arter-
ies of the contralateral myometrium. Serial sonographic ex-
aminations were performed so as to determine the morphol-
ogy and volume of the “scars.”
Statistical Analysis
All results are expressed as mean  standard deviation
(SD). Statistic analysis was made by using the unpaired
Student t test for the comparison of means between 2
groups (significance, P0.01).
For multiple comparison, the pair-wise t test was used.
The Pearson 
2 test was used for the comparison of
percentages between the groups.
P0.016 was considered the limit of statistical significance.
Technique
Myomectomies were performed with the standard tech-
nique7 with 3 ancillary suprapubic ports. Two suprapubic
access routes (5 mm and 10 mm) were inserted lateral to the
deep inferior epigastric arteries and slightly higher than usu-
al: the accessory trocars should be inserted sufficiently high
enough to provide an easy approach to the myomas for the
laparoscopic instruments. A third trocar (5mm) was inserted
in the midline, level to or higher than the other 2.
The uterus was always cannulated (MUR 18, Sofar, Trezzano
Rosa, Italy) to allow correct exposure of the myomas and
strong countertractions during enucleation and suturing. For
pedunculated myomas, bipolar forceps and scissors were
used for the smaller ones; otherwise, the pedicle was se-
cured by using a pretied or extracorporeally tied loop and
coagulated and transected with bipolar forceps and scissors.
To reduce vascularization and blood loss, starting in 1997,
we injected myomas with diluted ornithine vasopressin and
now diluted (20IU: 500mL) argipressin. The vasoconstrictive
agent was injected laparoscopically between the myome-
trium and the myoma capsule, looking for the cleavage
plane, until blanching occurred.
For subserosal and intramural myomas, a vertical incision
(hysterotomy), both for anterior and posterior myomas,
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through the myoma pseudocapsule with a unipolar hook
and high cutting current.
After exposure of the myoma, a grasping forceps was
positioned to apply traction on the myoma and to expose
the cleavage plane. Traction on the myoma applied with
tenaculum with a countertraction on the uterus-facilitated
dissection. Mechanical enucleation was advised whenever
possible. Division of the connective tissues surrounding
the myoma was obtained with a unipolar hook or with the
Ultrasonic Cutting and Coagulating System (SonoSurg,
Olympus, Japan), the latter having the advantage of less
tissue charring. The only exception to this technique was
in case of unsuspected adenomyosis. In this situation, the
cleavage plane does not exist, and excision can only be
carried out with a monopolar hook, sharp cutting, or an
ultrasonic energy device, paying attention to use electro-
surgery close to the myoma and not to the myometrium.
Regarding infra-ligamentous myomas, they usually are to
be considered as pedunculated or subserosal myomas
arising into the broad ligament. The peritoneum surround-
ing the myoma was incised. The myoma was gently enu-
cleated by the surrounding areolar tissue. Hemostasis
could be achieved with bipolar coagulation of the vessels
reaching the myoma, paying attention to dangerous struc-
tures, such as the ureter or uterine vessels. As the base of
the myoma was reached, coagulation of the blood supply
was obtained with bipolar forceps. Eventually the suture
was made.
For superficial subserosal myomas, suturing was usually
done along 1 plane. For subserosal myomas deeper than
1cm and for intramural myomas, it was always necessary
to make a suture in 2 layers because it consists of bringing
the entire thickness of the edges of the myomectomy site
together to prevent the formation of hematomas.
We used large, curved needles (CT 1, 30 mm to 40 mm)
swaged to Vicryl (1 or 0). For 1-layer sutures, we used
interrupted, simple or more frequently cross-stitches, tied
intracorporeally. For double-layer sutures, suturing was
usually done along different planes: one large stitch reach-
ing the deep layers and one more superficial suture to
introflect the serosa. As for double-layer closures, a run-
ning suture was used in 10% of cases. It was applied first
in the deeper plane, starting from the apex of the myo-
mectomy scar to the base, continuing along the more
superficial plane from the base to the apex. The suture
was in the end tied intracorporeally with the tail of the
running suture.
RESULTS
From January 1991 to December 2003, we were able to
follow-up 332 patients who underwent single or multiple
myomectomies for symptomatic myomas measuring at least
4cm in diameter and being 8 in number (Table 1). Most
patients (47%) had more than one myoma, with a maximum
of 8 per patient (average number of myomas removed, 2.23;
range, 1 to 8). Myoma size ranged from 1 cm to 20 cm
(average 60.20SD27.1 mm). Myomas 4 cm were re-
moved during myomectomy for larger ones. The conversion
rate to laparotomy was 1.51%. We converted to laparotomy
in 3 cases because of anesthesiologic problems: in one case
because of the number and size of the myomas, in another
for a large infra-ligamentous myoma. In both of the last
cases, conversions were due to difficulties in mobilizing the
myoma in a narrow space. The average drop in hemoglobin
concentration was 1.06SD0.86 g/100 mL (range, 0.7 to 2.2
g/100 mL). No blood transfusions were required. No major
intraoperative complications occurred. We had 2 serious
postoperative complications: a temporary kidney failure
probably due to excessive low blood pressure in the patient
during the entire duration of the procedure and a bowel
perforation in a patient with multiple retroperitoneal myo-
mas. The duration of the entire procedure ranged from 30
minutes to 360 minutes (mean, 124SD52.6). The patients
did not differ among the 3 groups for age and number of
myomas removed. Instead, the dimension of the greater
myoma increased with experience (4.91SD2.2 cm in the
earlier cases to 6.76SD2.7 in Group III, P0.000). The
learning curve positively influenced the length of the proce-
dures in the first cases. Considering the 3 groups, the oper-
ating time varied from 142.27SD58.32 minutes in Group I
to 118.66SD49.8 in Group III (P0.003). Nevertheless,
these data can be confounding because of the numerous
variables involved. To avoid them, we considered only pro-
cedures for single myoma 6cm to 8cm in diameter. In these
cases, the operating time varied from a mean of 158 minutes
from 1992 to 1993 to 140 from 1994 to 95 (P0.01). This
parameter considered only the learning curve. In fact, the
electromechanical morcellator had not yet been used.
The introduction of electromechanical morcellation in
1996 significantly reduced the procedure time. Again con-
sidering only procedures for single intramural myomas
6cm to 8cm in diameter, the length of the procedure
dropped from a mean of 156 minutes in Group I to 107 in
Group II (P0.000), but still the morcellation time of the
procedure is unfavorably time consuming. Considering
only single myomectomies, data showed a significantly
reduced Hb drop after the introduction in 1998 of vaso-
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After the enthusiastic first results with the running suture,
which made us consider this technique faster than the
traditional interrupted suture, more definitive statistical
results showed that the running suture had no or even
fewer advantages in terms of procedure time. Instead, it
had advantages in terms of hemoglobin drop (Hb 1.1
g/100 mL vs 0.61, P0.01).
The preoperative ultrasonographic examinations showed
accentuation of the vascularity at the level of identifiable
myomas with a decrease of PI and RI, similar to that in
previous reports.8,9 Diastolic flow in these arteries was
always present and increased in comparison with blood
flow in the normal myometrium. Thirty patients were
randomized for laparoscopic and laparotomic myomecto-
mies and compared for clinical results and postoperative
US findings. The 2 groups were homogeneous for preop-
erative clinical features as well as for myoma volume and
number (Table 2). Sonographic evaluations performed 7
days to 15 days after the intervention showed a remark-
Table 1.
Demographic Characteristics of Patients and Outcome Measures
Groups I, II, III* Group I* Group II* Group III* Significance†
All Myomectomies
No. patients 332 90 33 209
Patient age (Mean yr  SD) 35.47  4.8 35.76  4.2 34.36  5.1 35.517  4.9 NS
Myoma no. (Mean  SD) 2.238  1.7 2.42  1.85 1.63  1.16 2.25  1.8 I vs II: P  0.0065
Myoma diameter
(Mean cm  SD)
6.20  2.7 4.91  2.2 6.18  1.9 6.76  2.7 III vs I: P  0.0000
II vs I: P  0.0163
Operating time
(Mean min  SD)
124.021  52.2 142.27  58.32 122.18  35.39 118.66  49.8 III vs I: P  0.0003
II vs I: P  0.0012
HB drop (Mean g/mL  SD) 1.06  0.8 1.11  0.47 0.68  0.47 1.11  0.9 I vs III: NS
Hospital stay
(Mean days  SD)
2.0  0.57 2.0  0.73 1.8  0.58 2.04  0.43 NS
Single Intramural Myoma 6 cm to 8 cm in Diameter
No. patients 98 16 9 73
Operating time
(Mean min  SD)
116.27  31.8 156.87  25.2 106.66  21.8 108.56  27.2 I vs II: P  0.0000
I vs III: P  0.0000
HB drop (Mean g/mL  SD) 1.03  0.8 1.62  0.8 1.39  0.5 0.90  0.4 I vs III: P  0.0011
I vs II: P  0.0078
*Group I  earlier years; Group II  introduction of electromechanical morcellator; Group III  introduction of vasoconstrictive agents.
†P  0.016 was considered as statistically significant.
Table 2.
Randomized Groups for US Color Doppler Study of the Myomectomy Scar Demographic Characteristics and Clinical Outcomes
Laparoscopy and
Laparotomy
Laparotomy Laparoscopy Significance
Number of patients 30 10 20 NS
Median age [median yr
(range)]
36 (26–42) 35 (26–39) 36 (29–42) NS
Myoma size [median cm;
mean  SD (range)]
5; 5.4  3.68 (1–10) 5; 5.3  3.59 (2–10) 5; 5.5  3.75 (1–9) NS
Myomas removed per
patient
1.2 1.4 1.1 NS
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myomectomy scar along with a further slight reduction in
PI and RI. The following US examinations demonstrated a
progressive reduction in this hyper-vascularity that 45
days after the surgery was absolutely indistinguishable
from the vascularity of the surrounding myometrium. PI
and RI gradually increased to be the same as the indexes
in the intact myometrium. The myomectomy wound visu-
alized as only 1 ultrasonic pattern of a highly echogenic
area with an ill-defined, heterogeneous myometrial tex-
ture. A progressive reduction in scar size was also re-
ported. Moreover, postoperative US examinations showed
the absence of hematomas in the site of the myomectomy
wound. US findings after laparoscopic or laparotomic
myomectomy were comparable (P0.2).10
The overall rate of intrauterine pregnancy following LM
was 65.5%. No uterine ruptures were observed. The preg-
nancy rate after laparoscopic myomectomy was similar to
the pregnancy rate reported after laparotomic myomectomy.
DISCUSSION
Laparoscopic myomectomy is still a controversial proce-
dure whose feasibility and indications over the years have
been greatly discussed.4,11,12 Sensational reports in the
literature13–17 focus attention on the wrong techniques or
adverse events. Concerns regarding uterine wall integrity
and stability after surgery, the undoubtedly long operating
time, the supposed higher recurrence rate,6 and the tech-
nical difficulties due to myoma mobilization and laparo-
scopic suturing have made it mandatory to check the
technique used and the personal results.
Nine cases of uterine rupture after laparoscopic myomec-
tomy have been reported so far.13–17 Authors cite applica-
tion of excessive tissue coagulation, difficulties in tissue
approximation or use of unsuitable suture size18 with the
risk of intramural hematomas, indentations and uterine
fistulas as possible contributing factors. The problem
raised doubts about how solid the uterine wall is after
laparoscopic myomectomy for patients desiring preg-
nancy. To search into it, we studied vascularization of the
uterine wound after laparoscopic myomectomy by means
of transvaginal color Doppler ultrasonography. Changes
in the uterine scar following laparoscopic myomectomy
by means of ultrasonography and Doppler velocimetry of
the uterine arteries, measured at the origin of their ascend-
ing branch, have been reported19: uterine healing showed
a progressive reduction in the size of the scar, with a
statistically significant increase in the resistance index
value of the ipsilateral uterine artery. Times and condi-
tions of the vascular repair of the uterine “scar” at the site
of the myomectomy have not been investigated so far. We
studied vascularization of the uterine wound after laparo-
scopic and laparotomic myomectomy by means of trans-
vaginal color Doppler ultrasonography in comparison
with vascularity of the contralateral intact myometrium. In
this way, it was also possible to check for defective heal-
ing (hematomas, indentations) along the uterine scar in
the immediate postoperative period.
Transvaginal color Doppler can be used to study the
evolution of the “scar” following myomectomy. The heal-
ing process after laparoscopic myomectomy seems to be
as safe and uneventful as after laparotomic myomectomy:
the size of the uterine wound decreased steadily from the
day after the procedures to day 30 to 40 when it was
possible to assess the healing process. Vascularization in
the site of the myomectomy scar was also comparable
after laparoscopic and laparotomic procedures.
Results of this study make us believe that the risk of
uterine rupture is more related to incorrect technique for
tissue approximation rather than to endoscopic suturing
itself.
After reports of uterine ruptures following LM in case of
removal of pedunculated or subserosal myomas using
electrosurgery only,15,16 now we always apply sutures or
endoscopic loops. Suturing is usually done along one or
two layers depending on the depth of the incision. The
edges of the myomectomy site have to be thoroughly
reapproximated to avoid dead spaces and to prevent the
formation of hematomas. We used large, curved needles
(CT 1, 30 mm to 40 mm) swaged to Vicryl (1 or 0). In fact,
the use of unsuitable suture size (Vicryl 3 zero) has been
considered one factor predisposing patients to uterine
ruptures reported in the early cases.6,14 The running suture
was demonstrated to obtain a lower Hb drop (0.61 vs 1.1
g/100 mL; P0.01) but needs good teamwork and coor-
dination between surgeon and assistant. We had the im-
pression that this kind of suture was quicker, but after a
review of the statistical analysis avoiding confounding
factors, it appears to take longer.
Some authors
4, 20 suggest that no more than 3 or 4 myo-
mas with a diameter 7cm to 8cm are to be removed, but
others believe in individual choice based on pathologic
findings and surgical skill21. At the present time, we
choose not to perform laparoscopic myomectomies with
more than 5 to 7 large myomas because in these cases we
believe that the procedure is excessively time-consuming
and that the surgeon can miss the smaller myomas after
the uterus has been incised and repaired in too many
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still advocated, uterine artery embolization may be the
best choice. Moreover, in case of more than 3 or 4 myo-
mas, patients should be informed of the higher risk of
recurrences.
During the first years of the survey, we treated patients
with an elevated number of large myomas with GnRH
analogs to facilitate the surgery, reducing myoma volume.
We did not notice an improvement in the surgery given
that preoperative treatment with GnRH may increase dif-
ficulties in identifying and dissecting the cleavage plane
between the myoma and its pseudocapsule. According to
Dubuisson,22 GnRH analogs are one of the preoperative
factors that were found to be independently related to the
risk of conversion and, moreover, we had very strong
suggestions of a greater chance of not detecting myomas
because of their shrinkage after therapy with a higher risk
of recurrence in GnRH analog-treated patients.7
At the moment, we only treat women with serious anemia
due to persistent menometrorrhagia to improve hemoglo-
bin concentration before surgery. To reduce vasculariza-
tion and blood loss, starting in 1997, we injected myomas
with vasoconstrictive agents. Our data showed signifi-
cantly reduced Hb decline (P0.001) after the use of
vasoconstrictive agents.
The use of diluted vasoconstrictive agents has allowed the
minor use of electrosurgery to achieve hemostasis and
dissection in favor of sharp dissection. Nowadays, we
recommend mechanical enucleation of the myoma with m
inimal or no use of electrosurgery given that authors11,18
reported application of excessive tissue coagulation as
one of the possible contributing factors to uterine rupture
after LM.
Since 1993, several systems of electromechanical morcel-
lation have been available; nevertheless, myoma morcel-
lation is still the most time-consuming part of the entire
procedure. Operative time was significantly positively cor-
related with the dominant myoma diameter and the num-
ber of myomas. Considering the myoma as a spheroid, its
volume will exponentially increase while increasing its
diameter. The proposed posterior colpotomy is not suit-
able and does not correspond to the requirements of
minimally invasive surgery. Furthermore, an infectious
risk is involved that can lead to delayed postoperative
healing with intraabdominal adhesions.
The learning curve has positively influenced only the
enucleation-suturing part of the procedure and the capa-
bility to approach bigger myomas that were previously
discarded. The conversion rate and complication rate
have not differed over the years.
On the other hand, the improvements in morcellation
systems and grasping forceps, the end of the learning
curve in suturing, the increased confidence given by good
results reported worldwide have allowed a reduction in
operating time and the completion of more demanding
myomectomies. Table 3 shows how the experience has
modified the approach to myomectomy over the years.
Over the last 15 years, the gained experience and the
clinical results have changed our approach and decision
making regarding laparoscopic myomectomy. Our satis-
factory outcomes and extremely low conversion rate
(1.51%) suggest that laparoscopic myomectomy is a safe
and reliable procedure even in the presence of multiple or
Table 3.
Developments in Techniques of Myomectomy
Past Technique Present Technique
Pedunculated myomas Bipolar forceps Monopolar or bipolar current Suture or endoscopic loop
Vasoconstrictive agents No Diluted ornithine vasopressin and now, diluted (20 IU:500
ml) argipressin.
Enucleation Mostly with electrosurgery Mostly mechanical
Suture Vicryl 0 Single layer Vicryl 1 or 2 Two layers, single or continuous
Morcellation Manual Electromechanical
GnRH analogs for
myomas 6 cm Yes
No, only with persistent menometrorrhagia or Serious
anaemia
GnRH analogs for
myomas 10 cm Yes
Only in case of difficult mobilization
JSLS (2007)11:34–40 39enlarged myomas. Moreover, our pregnancy rate and
pregnancy outcome indicate that both wish for pregnancy
and infertility before surgery are not exclusion criteria for
the laparoscopic approach.
CONCLUSION
Laparoscopic myomectomy, when performed by an expe-
rienced surgeon, may be a safe technique and may offer
comparable results with those obtained with laparotomy.
Moreover, considering the high recurrence rate also with
laparotomy and the consequent risk of repeated surgery,
we think that patients should be offered the least invasive
surgical approach available.
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